XML 19 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues        
Revenues $ 84 $ 4,262 $ 84 $ 5,707
Costs and expenses        
Research and development 13,767 11,139 25,862 22,554
General and administrative 4,432 2,867 7,906 5,973
Depreciation 222 157 412 341
Total costs and expenses 18,421 14,163 34,180 28,868
Loss from operations (18,337) (9,901) (34,096) (23,161)
Other income (expense), net (35) 213 80 517
Net loss and comprehensive loss $ (18,372) $ (9,688) $ (34,016) $ (22,644)
Net loss per share, basic and diluted (in dollars per share) $ (0.10) $ (0.06) $ (0.19) $ (0.15)
Weighted average shares outstanding, basic and diluted (in shares) 191,317 150,163 177,016 148,075
Grant revenue        
Revenues        
Revenues $ 7 $ 69 $ 7 $ 73
Healios | Contract revenue        
Revenues        
Revenues $ 77 $ 4,193 $ 77 $ 5,634